Cargando…

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana

HIV is known to accumulate escape mutations in the gag gene in response to the immune response from cytotoxic T lymphocytes (CTLs). These mutations can occur within an individual as well as at a population level. The population of Botswana exhibits a high prevalence of HLA*B57 and HLA*B58, which are...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokaleng, Baitshepi, Choga, Wonderful Tatenda, Bareng, Ontlametse Thato, Maruapula, Dorcas, Ditshwanelo, Doreen, Kelentse, Nametso, Mokgethi, Patrick, Moraka, Natasha Onalenna, Motswaledi, Modisa Sekhamo, Tawe, Leabaneng, Koofhethile, Catherine Kegakilwe, Moyo, Sikhulile, Zachariah, Matshediso, Gaseitsiwe, Simani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221913/
https://www.ncbi.nlm.nih.gov/pubmed/37243104
http://dx.doi.org/10.3390/vaccines11051000
_version_ 1785049570249539584
author Mokaleng, Baitshepi
Choga, Wonderful Tatenda
Bareng, Ontlametse Thato
Maruapula, Dorcas
Ditshwanelo, Doreen
Kelentse, Nametso
Mokgethi, Patrick
Moraka, Natasha Onalenna
Motswaledi, Modisa Sekhamo
Tawe, Leabaneng
Koofhethile, Catherine Kegakilwe
Moyo, Sikhulile
Zachariah, Matshediso
Gaseitsiwe, Simani
author_facet Mokaleng, Baitshepi
Choga, Wonderful Tatenda
Bareng, Ontlametse Thato
Maruapula, Dorcas
Ditshwanelo, Doreen
Kelentse, Nametso
Mokgethi, Patrick
Moraka, Natasha Onalenna
Motswaledi, Modisa Sekhamo
Tawe, Leabaneng
Koofhethile, Catherine Kegakilwe
Moyo, Sikhulile
Zachariah, Matshediso
Gaseitsiwe, Simani
author_sort Mokaleng, Baitshepi
collection PubMed
description HIV is known to accumulate escape mutations in the gag gene in response to the immune response from cytotoxic T lymphocytes (CTLs). These mutations can occur within an individual as well as at a population level. The population of Botswana exhibits a high prevalence of HLA*B57 and HLA*B58, which are associated with effective immune control of HIV. In this retrospective cross-sectional investigation, HIV-1 gag gene sequences were analyzed from recently infected participants across two time periods which were 10 years apart: the early time point (ETP) and late time point (LTP). The prevalence of CTL escape mutations was relatively similar between the two time points—ETP (10.6%) and LTP (9.7%). The P17 protein had the most mutations (9.4%) out of the 36 mutations that were identified. Three mutations (A83T, K18R, Y79H) in P17 and T190A in P24 were unique to the ETP sequences at a prevalence of 2.4%, 4.9%, 7.3%, and 5%, respectively. Mutations unique to the LTP sequences were all in the P24 protein, including T190V (3%), E177D (6%), R264K (3%), G248D (1%), and M228L (11%). Mutation K331R was statistically higher in the ETP (10%) compared to the LTP (1%) sequences (p < 0.01), while H219Q was higher in the LTP (21%) compared to the ETP (5%) (p < 0.01). Phylogenetically, the gag sequences clustered dependently on the time points. We observed a slower adaptation of HIV-1C to CTL immune pressure at a population level in Botswana. These insights into the genetic diversity and sequence clustering of HIV-1C can aid in the design of future vaccine strategies.
format Online
Article
Text
id pubmed-10221913
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102219132023-05-28 No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana Mokaleng, Baitshepi Choga, Wonderful Tatenda Bareng, Ontlametse Thato Maruapula, Dorcas Ditshwanelo, Doreen Kelentse, Nametso Mokgethi, Patrick Moraka, Natasha Onalenna Motswaledi, Modisa Sekhamo Tawe, Leabaneng Koofhethile, Catherine Kegakilwe Moyo, Sikhulile Zachariah, Matshediso Gaseitsiwe, Simani Vaccines (Basel) Article HIV is known to accumulate escape mutations in the gag gene in response to the immune response from cytotoxic T lymphocytes (CTLs). These mutations can occur within an individual as well as at a population level. The population of Botswana exhibits a high prevalence of HLA*B57 and HLA*B58, which are associated with effective immune control of HIV. In this retrospective cross-sectional investigation, HIV-1 gag gene sequences were analyzed from recently infected participants across two time periods which were 10 years apart: the early time point (ETP) and late time point (LTP). The prevalence of CTL escape mutations was relatively similar between the two time points—ETP (10.6%) and LTP (9.7%). The P17 protein had the most mutations (9.4%) out of the 36 mutations that were identified. Three mutations (A83T, K18R, Y79H) in P17 and T190A in P24 were unique to the ETP sequences at a prevalence of 2.4%, 4.9%, 7.3%, and 5%, respectively. Mutations unique to the LTP sequences were all in the P24 protein, including T190V (3%), E177D (6%), R264K (3%), G248D (1%), and M228L (11%). Mutation K331R was statistically higher in the ETP (10%) compared to the LTP (1%) sequences (p < 0.01), while H219Q was higher in the LTP (21%) compared to the ETP (5%) (p < 0.01). Phylogenetically, the gag sequences clustered dependently on the time points. We observed a slower adaptation of HIV-1C to CTL immune pressure at a population level in Botswana. These insights into the genetic diversity and sequence clustering of HIV-1C can aid in the design of future vaccine strategies. MDPI 2023-05-19 /pmc/articles/PMC10221913/ /pubmed/37243104 http://dx.doi.org/10.3390/vaccines11051000 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mokaleng, Baitshepi
Choga, Wonderful Tatenda
Bareng, Ontlametse Thato
Maruapula, Dorcas
Ditshwanelo, Doreen
Kelentse, Nametso
Mokgethi, Patrick
Moraka, Natasha Onalenna
Motswaledi, Modisa Sekhamo
Tawe, Leabaneng
Koofhethile, Catherine Kegakilwe
Moyo, Sikhulile
Zachariah, Matshediso
Gaseitsiwe, Simani
No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
title No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
title_full No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
title_fullStr No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
title_full_unstemmed No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
title_short No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
title_sort no difference in the prevalence of hiv-1 gag cytotoxic t-lymphocyte-associated escape mutations in viral sequences from early and late parts of the hiv-1 subtype c pandemic in botswana
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221913/
https://www.ncbi.nlm.nih.gov/pubmed/37243104
http://dx.doi.org/10.3390/vaccines11051000
work_keys_str_mv AT mokalengbaitshepi nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT chogawonderfultatenda nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT barengontlametsethato nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT maruapuladorcas nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT ditshwanelodoreen nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT kelentsenametso nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT mokgethipatrick nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT morakanatashaonalenna nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT motswaledimodisasekhamo nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT taweleabaneng nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT koofhethilecatherinekegakilwe nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT moyosikhulile nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT zachariahmatshediso nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana
AT gaseitsiwesimani nodifferenceintheprevalenceofhiv1gagcytotoxictlymphocyteassociatedescapemutationsinviralsequencesfromearlyandlatepartsofthehiv1subtypecpandemicinbotswana